Visit the CB2 Insights Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
Sail Selected by the Association of Cannabis Specialists to Empower U.S. Physicians With Clinical Decision Support Platform
CDS platform to be implemented across multiple states to provide medical cannabis qualification, dosing and certification support at the point-of-care
TORONTO, May 16, 2018 (GLOBE NEWSWIRE) — Sail, a global leader in medical cannabis-focused software used by clinicians and patients at the point-of-care, today announced that The Association of Cannabis Specialists (ACS) has selected the company’s SailMD platform to be implemented across the practices of more than 300-member physicians in the United States. Sail’s Clinical Decision Support (CDS) platform delivers a comprehensive toolset to guide clinicians through the necessary steps when integrating medical cannabis into a patient’s treatment regimen.
At ACS, our mission is to ensure the highest standards in the practice of cannabis medicine and safeguard patients with clinical best practices. The SailMD CDS tool brings an unprecedented knowledge-based solution to the point-of-care that will help our members when qualifying, recommending and certifying medical cannabis within their practices.
Dr. Jordan Tishler, M.D., President, Association of Cannabis Specialists
The ACS continues to be at the center of the medical cannabis industry evolution. Recognized as one of the most respected advocacy groups on behalf of patients and health care practitioners, the ACS has provided resources, education, political action and other services that have had a lasting impact on improved patient care. As international markets continue their own evolution on the subject, Sail will ensure that ACS has the tools required to serve those markets additionally.
SailMD works to close the knowledge gap for health care practitioners when it comes to medical cannabis. The CDS platform guides the clinician through patient-specific questionnaires pertaining to conditions, symptoms, previous treatment strategies and other necessary medical protocols. Based on that data collection, the platform generates individualized profiles illustrating any potential concerns there may be for certifying that patient for medical cannabis treatment. Should the treatment option be deemed appropriate by the clinician, the system is able to create the electronic medical document and submit it to the necessary regulatory bodies and/or medical cannabis distribution channels depending on the regional requirements.
Our goal has always been simple. We bring clinically-validated, easy-to-use healthcare tools and protocols to the medical cannabis industry. As we continue to watch the rapid adoption of medical cannabis across the globe, clinicians and patients need tools to simplify the qualification process, provide educational resources and ensure total compliance in each country or each state.
Prad Sekar, Chief Executive Officer of Sail
We are proud that an organization like the ACS, which is so steeped in best practice advocacy, sees our SailMD platform as an integral part of this industry evolution.
The SailMD platform along with the Company’s other software solutions are currently used in multiple countries and in multiple states throughout the US. Sail is uniquely used at every touch point in the medical cannabis ecosystem including clinicians, patients, licensed producers, dispensaries and other stakeholders in the industry – enabling a holistic view from end to end.
Sail’s mission is to simplify the medical cannabis journey through a suite of healthcare technology products and solutions such as its Clinical Decision Support platform, fully managed service business, patient engagement tools and clinical research group. Sail’s solutions work to close the knowledge gap between physicians, patents, distributors, wholesalers and other key stakeholders within the medical cannabis ecosystem. Sail is a subsidiary of MVC Technologies Inc.
About the Association of Cannabis Specialists
The Association of Cannabis Specialists (ACS) ensures the highest standards in the practice of cannabis medicine, safeguards patient care with clinical best practices, and interfaces with other stakeholders in the cannabis community. ACS believes that patients are uniquely vulnerable and have very different needs than recreational users. ACS provides evidence and experience-based education for patients, cannabis clinicians, referring clinicians, and lawmakers to help them understand cannabis medicine and make informed decisions. ACS is a political organization striving to implement best practices in the laws and regulations at the federal, state, and international levels.
The most reliable, fact-based information on Cb2 Insights found only on its Investor Dashboard.